Legal Notice
Please click the 'ACCEPT' button at the bottom of this page if the following terms and conditions are acceptable. We will remember your selection for 30 days.

MATERIALS ON THIS WEBSITE ARE MADE AVAILABLE BY CRYSTAL AMBER FUND LIMITED FOR INFORMATION PURPOSES ONLY.

THESE MATERIALS ARE NOT DIRECTED AT, NOR ARE THEY INTENDED FOR USE BY, PERSONS LOCATED OR RESIDENT IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN.

Please read the disclaimers below carefully, as by using the Crystal Amber Fund Limited website you will be taken to have agreed to be bound by them.

Please note that the disclaimers set out below may be altered or updated. You should read them in full each time you visit this website.

The information on this website may change from time to time and this website may not be kept up to date. Neither Crystal Amber Fund Limited, Global Fund Management Services Limited nor Tarncourt Asset Management Limited shall be liable for any out of date information.

Any person viewing this website certifies that: (i) they are not located in the United States and are not a U.S. person (as such terms are defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act")) and (ii) they are not located in Canada, Australia, South Africa or Japan.

For the purposes of clarification, the documents and information presented on this website are solely for information purposes and nothing contained in these website pages constitutes or forms part of any offer, or any solicitation of any offer, or any inducement, advertisement or promotion, in relation to: (i) any securities, investments, products or services in any jurisdiction or (ii) any prospective contract with Crystal Amber Fund Limited or any other company. The information provided and the fact of its distribution shall not form the basis of, or be relied upon in connection with, any contract, commitment or investment decision. The information contained within this website does not constitute financial, professional or investment advice. If you are in any doubt you should consult your own independent financial adviser, stockbroker, solicitor, accountant or other professional adviser.

Past performance is no guide to the future. The value of investments and the income from them may go down as well as up and investors may not get back the full amount they originally invested. The information herein has been obtained from sources believed to be reliable but no representation or warranty is given or may be implied that they are accurate or complete.

Viewing information on this site or otherwise receiving information in relation to Crystal Amber Fund Limited may not be lawful in certain jurisdictions. In other jurisdictions only certain categories of person may be allowed to view this information. A person who wishes to view this site must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so. If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials please exit the website.

Access to electronic versions of the various materials presented at this website is being made available in good faith and for information purposes only. Any person seeking access to this site represents and warrants to Crystal Amber Fund Limited that they are doing so for information purposes only. Making press announcements and other information available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy securities in Crystal Amber Fund Limited anywhere in the world. Further, it does not constitute a recommendation by Crystal Amber Fund Limited, Global Fund Management Services Limited, Tarncourt Asset Management Limited or any other person to sell or buy securities in Crystal Amber Fund Limited or otherwise. These materials do not constitute an invitation or advice to underwrite, subscribe for, or otherwise acquire or dispose of, securities in Crystal Amber Fund Limited.

Any securities or related instruments of the Crystal Amber Fund Limited discussed or referred to in the materials on this website have not been, and will not be, registered under the Securities Act, or under the securities legislation of any state of the United States. Accordingly, any such securities may not, directly or indirectly, be offered, sold pledged or otherwise transferred, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons (as such terms are defined in Regulation S under the Securities Act) unless the securities are registered under the Securities Act and the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act") or exemptions from the registration requirements of the Securities Act and the Investment Company Act are available. Any securities or related instruments of the Crystal Amber Fund Limited discussed or referred to in the materials on this website have not been recommended by any U.S. federal or state securities commission or regulatory authority nor have any such authorities confirmed the accuracy or adequacy of the various materials presented on this website. Any representation to the contrary is a criminal offence in the United States. Hedging transactions involving such securities may not be conducted unless in compliance with the Securities Act.

The Fund is not incorporated in the UK and the rights of shareholders may be different from the rights of shareholders in a UK incorporated company. 
AcceptDecline
Please note: If you are unable to proceed after clicking the 'ACCEPT' button above, you will need to ensure cookies are enabled on the browser you are using. Crystal Amber will not store or use any personal information we obtain from you, the use of a cookie is used to ensure your acceptance of this disclaimer.
News
27th December 2024Form 8.3 - De La Rue plcView Document
19th December 2024Monthly Net Asset ValueView Document
13th December 2024Result of AGMView Document
3rd December 2024Further investment into Morphic Medical IncView Document
19th November 2024Monthly Net Asset ValueView Document
18th November 2024Monthly Net Asset ValueView Document
13th November 2024Posting of Annual Report and Notice of AGMView Document
12th November 2024Final ResultsView Document
28th October 2024Result of Extraordinary General MeetingView Document
9th October 2024Proposed B share scheme and notice of GMView Document
1st October 2024Monthly Net Asset ValueView Document
11th September 2024Monthly Net Asset ValueView Document
30th August 2024Total Voting RightsView Document
23rd August 2024Holding(s) in CompanyView Document
20th August 2024Transaction in Own Shares and Total Voting RightsView Document
16th August 2024Holding(s) in CompanyView Document
16th August 2024Director/PDMR ShareholdingView Document
16th August 2024Transaction in Own Shares and Total Voting RightsView Document
15th August 2024Transaction in Own Shares and Total Voting RightsView Document
14th August 2024Transaction in Own Shares and Total Voting RightsView Document
12th August 2024Extension to Share Buyback ProgrammeView Document
31st July 2024Total Voting RightsView Document
31st July 2024Investee company update: Morphic Medical Inc.View Document
31st July 2024Monthly Net Asset ValueView Document
26th July 2024Transaction in Own Shares and Total Voting RightsView Document
23rd July 2024Transaction in Own Shares and Total Voting RightsView Document
3rd July 2024Transaction in Own Shares and Total Voting RightsView Document
28th June 2024Total Voting RightsView Document
21st June 2024Transaction in Own Shares and Total Voting RightsView Document
19th June 2024Monthly Net Asset ValueView Document
18th June 2024Transaction in Own Shares and Total Voting RightsView Document
7th June 2024Transaction in Own Shares and Total Voting RightsView Document
6th June 2024Transaction in Own Shares and Total Voting RightsView Document
5th June 2024Transaction in Own Shares and Total Voting RightsView Document
4th June 2024Holding(s) in CompanyView Document
4th June 2024Holding(s) in CompanyView Document
4th June 2024Morphic Medical – FDA approval of study amendmentsView Document
3rd June 2024Transaction in Own Shares and Total Voting RightsView Document
3rd June 2024Total Voting RightsView Document
31st May 2024Transaction in Own SharesView Document
31st May 2024Transaction in Own SharesView Document
23rd May 2024Monthly Net Asset ValueView Document
23rd May 2024Extension to Share Buyback ProgrammeView Document
22nd May 2024Transaction in Own SharesView Document
17th May 2024Transaction in Own SharesView Document
3rd May 2024Holding(s) in CompanyView Document
2nd May 2024Holding(s) in CompanyView Document
1st May 2024Transaction in Own SharesView Document
30th April 2024Total Voting RightsView Document
29th April 2024Holding(s) in CompanyView Document
26th April 2024Transaction in Own SharesView Document
25th April 2024Holding(s) in CompanyView Document
24th April 2024Monthly Net Asset ValueView Document
24th April 2024Transaction in Own SharesView Document
12th April 2024Transaction in Own SharesView Document
10th April 2024Transaction in Own SharesView Document
3rd April 2024Monthly Net Asset ValueView Document
3rd April 2024Transaction in Own SharesView Document
2nd April 2024Extension to Share Buyback ProgrammeView Document
28th March 2024Total Voting RightsView Document
28th March 2024Half-year ReportView Document
27th March 2024Transaction in Own SharesView Document
22nd March 2024Transaction in Own SharesView Document
18th March 2024Transaction in Own SharesView Document
18th March 2024Transaction in Own SharesView Document
13th March 2024Transaction in Own SharesView Document
11th March 2024Transaction in Own SharesView Document
7th March 2024Transaction in Own SharesView Document
29th February 2024Total Voting RightsView Document
27th February 2024Director/PDMR DealingView Document
27th February 2024Notice of Interim Results and Portfolio UpdateView Document
26th February 2024Transaction in Own SharesView Document
26th February 2024Transaction in Own SharesView Document
22nd February 2024Transaction in Own SharesView Document
22nd February 2024Monthly Net Asset ValueView Document
22nd February 2024Transaction in Own SharesView Document
19th February 2024Transaction in Own SharesView Document
14th February 2024Transaction in Own SharesView Document
13th February 2024Holding(s) in CompanyView Document
2nd February 2024Transaction in Own SharesView Document
1st February 2024Transaction in Own SharesView Document
1st February 2024Total Voting Rights and Transaction in Own SharesView Document
30th January 2024Holding(s) in CompanyView Document
30th January 2024Holding(s) in CompanyView Document
29th January 2024Extension to Share Buyback ProgrammeView Document
26th January 2024Transaction in Own SharesView Document
25th January 2024Replacement - Director/PDMR ShareholdingView Document
24th January 2024Transaction in Own SharesView Document
24th January 2024Director/PDMR ShareholdingView Document
24th January 2024Director/PDMR ShareholdingView Document
23rd January 2024Transaction in Own SharesView Document
23rd January 2024Holding(s) in CompanyView Document
22nd January 2024Transaction in Own SharesView Document
22nd January 2024Monthly Net Asset ValueView Document
19th January 2024Transaction in Own SharesView Document
17th January 2024Transaction in Own SharesView Document
16th January 2024Transaction in Own SharesView Document
15th January 2024Transaction in Own SharesView Document
11th January 2024Transaction in Own SharesView Document
8th January 2024Transaction in Own SharesView Document
3rd January 2024Transaction in Own SharesView Document
2nd January 2024Transaction in Own SharesView Document
2nd January 2024Total Voting RightsView Document
2nd January 2024Transaction in Own SharesView Document